Cerus Corporation

Financials

Activos totales 221.41 M237.5 M218.09 M197.75 M200.92 M221.86 M Total de pasivos 117.61 M151.88 M149.53 M144.3 M144.02 M156.89 M Capital total 103.81 M85.62 M68.56 M53.44 M56.9 M64.97 M Total de pasivos y patrimonio neto 221.41 M237.5 M218.09 M197.75 M200.92 M221.86 M Deuda total 48.1 M69.42 M69.8 M79.8 M84.16 M83.89 M Deuda neta -66.7 M-41.77 M-14.92 M30.15 M17.64 M14.07 M

Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry.

CERS

Financials

Cerus Corporation

Noticias

Jensen, directora jurídica de Cerus Corp, vende acciones por 187.000 dólares

Jensen, directora legal de Cerus Corp, vende acciones por $187k

Jensen, Cerus Corp chief legal officer, sells $187k in stock

COO de Cerus Corp, Jayaraman, vende acciones por 273.000 dólares

Cerus Corp: director médico Benjamin vende acciones por 168.000 dólares

El director ejecutivo de Cerus Corp, Greenman, vende acciones por 742.000 dólares

El director financiero de Cerus Corp vende acciones por 211.000 dólares

COO de Cerus Corp, Jayaraman, vende acciones por $273 mil

CFO de Cerus Corp vende acciones por $211,000

Cerus Corp COO Jayaraman sells $273k in shares

Cerus Corp CEO Greenman sells $742k in shares

Cerus Corp: chief medical officer Benjamin sells $168k in shares